Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 – 2009

Bibliography

• Krishnamurthy VM, Kaufman GK, Urbach AR, Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein− ligand binding. Chem Rev 2008;108:946-1051
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81
   PubMed Web of Science ®Google Scholar
• Brahimi-Horn MC, Pouyssegur J. HIF at a glance. J Cell Sci 2009;122:1055-57
   PubMed Web of Science ®Google Scholar
• Wykoff CC, Beasley NJ, Watson PH, Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000:60:7075–83
   PubMed Web of Science ®Google Scholar
• Potter CPS, Harris AL. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 2003;89:2-7
   PubMed Web of Science ®Google Scholar
• Kaluz S, Kaluzova M, Liao S-Y, Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show? Biochim Biophys Acta Rev Cancer 2009;1795:162-72
   PubMed Web of Science ®Google Scholar
• Opavský R, Pastoreková S, Zelník V, Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships. Genomics 1996;33:480-87
   PubMed Web of Science ®Google Scholar
• Chiche J, Ilc K, Laferrière J, Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009;69:358-68
   PubMed Web of Science ®Google Scholar
• Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 2007;26:299-310
   PubMed Web of Science ®Google Scholar
• Martinez-Zaguilan R, Seftor EA, Seftor RE, Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 1996;14:176-86
   PubMed Web of Science ®Google Scholar
• Swietach P, Wigfield S, Cobden P, Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths. J Biol Chem 2008;283:20473-83
   PubMed Web of Science ®Google Scholar
• Swietach P, Patiar S, Supuran CT, The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growths. J Biol Chem 2009;284:20299-310
   PubMed Web of Science ®Google Scholar
• Svastova E, Hulikova A, Rafajova M, Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 2004;577:439-45
   PubMed Web of Science ®Google Scholar
• Divgi CR, Bander NH, Scott AM, Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin Cancer Res 1998;4:2729-39
   PubMed Web of Science ®Google Scholar
• Grabmaier K, Vissers JL, De Weijert MC, Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int J Cancer 2000;85:865-70
   PubMed Web of Science ®Google Scholar
• Lopez M, Bornaghi LF, Innocenti A, Sulfonamide linked neoglycoconjugates – a new class of inhibitors for cancer-associated carbonic anhydrases. J Med Chem 2010;53:2913-26
   Google Scholar
• Lopez M, Paul B, Hofmann A, S-glycosyl primary sulfonamides – A new structural class for selective inhibition of cancer-associated carbonic anhydrases. J Med Chem 2009;52:6421-32
   PubMed Web of Science ®Google Scholar
• Supuran C, Scozzafava A, Pastorekova S, Pastorek J. Sulfonamide carbonic anhydrase IX-specific inhibitors for the treatment of preneoplastic and neoplastic diseases. WO048544; 2004
   Google Scholar
• Winum J-Y, Poulsen S-A, Supuran CT. Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med Res Rev 2009;29:419-35
   PubMed Web of Science ®Google Scholar
• Winum J-Y, Rami M, Scozzafava A, Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445-63
   PubMed Web of Science ®Google Scholar
• Stiti M, Cecchi A, Rami M, Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. J Am Chem Soc 2008;130:16130-1
   PubMed Web of Science ®Google Scholar
• Nicox SA. Nitrate esters of carbonic anhydrase inhibitors. WO071421; 2008
   Google Scholar
• Solvay Pharmaceuticals GMBH. Novel sulfamate compounds for medical use. WO050252; 2009
   Google Scholar
• Maryanoff BE. Pharmaceutical “gold” from neurostabilizing agents: Topiramate and successor molecules. J Med Chem 2009;52:3431-40
   Google Scholar
• Casini A, Antel J, Abbate F, Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett 2003;13:841-45
   PubMed Web of Science ®Google Scholar
• Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Sulfamates and their therapeutic potential. Med Res Rev 2005;25:186-228
   PubMed Web of Science ®Google Scholar
• Okada M, Iwashita S, Koizumi N. Efficient general method for sulfamoylation of a hydroxyl group. Tetrahedron Lett 2000;41:7047-51
   Google Scholar
• Biotechnologijos Institutas. Benzimidazo[1,2,-c][1,2,3]thiadiazol-7-sulfonamides as CA inhibitors. WO016288; 2008
   Google Scholar
• Dudutiene V, Baranauskiene L, Matulis D. Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase. Bioorg Med Chem Lett 2007;17:3335-38
   PubMed Web of Science ®Google Scholar
• Siemens Medical Solutions USA, Inc. The development of molecular imaging probes for carbonic anhydrase-IX using click chemistry. WO124703; 2008
   Google Scholar
• Scozzafava A, Menabuoni L, Mincione L, Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring? J Med Chem 1999:42:2641-50
   PubMed Web of Science ®Google Scholar
• Wilkinson BL, Bornaghi LF, Houston TA, A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by “click-tailing”. J Med Chem 2006;49:6539-48
   PubMed Web of Science ®Google Scholar
• Poulsen S-A, Bornaghi LF. Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilising alkene cross metathesis. Bioorg Med Chem 2006;14:3275-84
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Conway J. Carbonic Anhydrase: Its Inhibitors and Activators. CRC Press, Florida; 2004
   Google Scholar
• Molecular Insight Pharmaceuticals, Inc. Inhibitors of carbonic anhydrase IX. WO089383; 2009
   Google Scholar
• Druker BJ. Perspectives on the development of imatinib and the future of cancer research. Nat Med 2009;15:1149-52
   PubMed Web of Science ®Google Scholar
• Hughes B. 2009 FDA drug approvals. Nat Rev Drug Discov 2010;9:89-92
   PubMed Web of Science ®Google Scholar
• Collins I, Workman P. New approaches to molecular cancer therapeutics. Nat Chem Biol 2006;2:689-700
   PubMed Web of Science ®Google Scholar